(Q40552884)

21 September 2017

1 reference

title

Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents (English)

1 reference

21 September 2017

3

J H Beijnen

1 reference

21 September 2017

D M Burger

1

1 reference

21 September 2017

P L Meenhorst

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

International Journal of Clinical Pharmacy

21 September 2017

published in

1 reference

21 September 2017

volume

17

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

25-30

1 reference

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

The effect of a protein meal on zidovudine pharmacokinetics in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Extrahepatic metabolism of zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01875051

Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of zidovudine in patients with liver cirrhosis

1 reference

12 December 2020

1 reference

12 December 2020

Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal.

1 reference

12 December 2020

Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus

1 reference

12 December 2020

Transfer and metabolism of dideoxyinosine by the perfused human placenta

1 reference

12 December 2020

Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group

1 reference

12 December 2020

Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group

1 reference

12 December 2020

Pharmacokinetic disposition of zidovudine during pregnancy

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Erratic zidovudine bioavailability in HIV seropositive patients

1 reference

12 December 2020

Therapy for human immunodeficiency virus infection

1 reference

12 December 2020

Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex

1 reference

12 December 2020

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection

1 reference

12 December 2020

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis

1 reference

12 December 2020

Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal

1 reference

12 December 2020

Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy

1 reference

12 December 2020

Fetoplacental passage of 2',3'-dideoxyinosine

1 reference

12 December 2020

Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease

1 reference

12 December 2020

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

1 reference

12 December 2020

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV-infected patients

1 reference

12 December 2020

The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys

1 reference

12 December 2020

Food-induced reduction in bioavailability of didanosine.

1 reference

12 December 2020

Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations

1 reference

12 December 2020

Zidovudine Pharmacokinetics During Pregnancy

1 reference

12 December 2020

The pharmacokinetics of zidovudine administered by continuous infusion in children

1 reference

12 December 2020

Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors

1 reference

12 December 2020

2',3'-dideoxyinosine (ddI): its chemical stability and cyclodextrin complexation in aqueous media

1 reference

12 December 2020

Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen

1 reference

12 December 2020

A method for the quantification of intracellular zidovudine nucleotides

1 reference

12 December 2020

Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine

1 reference

12 December 2020

1 reference

12 December 2020

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection

1 reference

12 December 2020

Comparative pharmacokinetics of antiviral nucleoside analogues

1 reference

12 December 2020

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01875051

1 reference

21 September 2017

1 reference